Sectors
CAMP
CAMP4 THERAPEUTICS CORPORATION
4.24
2 x 2.94
2 x 5.46
bid
ask
+
0.21
5.21%
2 @ 07:30 PM
4.24 +0.00 (0.00%)
| Ytd | -30.83% | |
| 1y | 69.60% |
3.94
day range
4.25
2.28
52 week range
7.13
| Open | 4.03 | Prev Close | 4.03 | Low | 3.94 | High | 4.25 | Mkt Cap | 266.07M |
| Vol | 1.04M | Avg Vol | 276.23K | EPS | -2.31 | P/E | N/A | Forward P/E | -2.52 |
| Beta | 0.27 | Short Ratio | 2.72 | Inst. Own | 42.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 4.10 | 200-d Avg | 4.51 | 1yr Est | 19.91 |
| Income Statement | |||
| Total Revenue | 1.78M | ||
| Revenues (USD) | 1.78M | ||
| Gross Profit | 1.78M | ||
| Operating Expenses | 15.16M | ||
| Research and Development Expense | 10.82M | ||
| Selling, General and Administrative Expense | 4.34M | ||
| Operating Income | -13.38M | ||
| Net Income | -33.53M | ||
| Net Income Common Stock | -33.53M | ||
| Net Income Common Stock (USD) | -33.53M | ||
| Consolidated Income | -33.53M | ||
| Earnings per Basic Share | -0.58 | ||
| Earnings per Basic Share (USD) | -0.58 | ||
| Earnings per Diluted Share | -0.58 | ||
| Earning Before Interest & Taxes (EBIT) | -33.53M | ||
| Earning Before Interest & Taxes (USD) | -33.53M | ||
| Weighted Average Shares | 57.93M | ||
| Weighted Average Shares Diluted | 57.93M | ||
| Balance Sheet | |||
| Cash and Equivalents | 87.13M | ||
| Cash and Equivalents (USD) | 87.13M | ||
| Investments | 894.00K | ||
| Investments Non-Current | 894.00K | ||
| Current Assets | 90.03M | ||
| Property, Plant & Equipment Net | 2.44M | ||
| Total Assets | 93.43M | ||
| Debt Current | 802.00K | ||
| Total Debt | 2.37M | ||
| Current Liabilities | 19.14M | ||
| Debt Non-Current | 1.57M | ||
| Total Liabilities | 94.12M | ||
| Accumulated Retained Earnings (Deficit) | -344.02M | ||
| Shareholders Equity | -693.00K | ||
| Shareholders Equity (USD) | -693.00K | ||
| Assets Non-Current | 3.40M | ||
| Total Debt (USD) | 2.37M | ||
| Deferred Revenue | 14.51M | ||
| Liabilities Non-Current | 74.98M | ||
| Trade and Non-Trade Payables | 1.09M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 577.00K | ||
| Net Cash Flow from Financing | 4.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -12.81M | ||
| Capital Expenditure | -129.00K | ||
| Issuance (Purchase) of Equity Shares | 4.00K | ||
| Net Cash Flow from Investing | -129.00K | ||
| Net Cash Flow from Operations | -12.69M | ||
| Share Based Compensation | 1.93M | ||